Lv12
48 积分 2024-07-05 加入
Autoimmune chronic spontaneous urticaria
1天前
已完结
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer
11天前
已完结
Efficacy and Safety of Zimlovisertib, Ritlecitinib, and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
14天前
已完结
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
21天前
已完结
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
25天前
已完结
Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment
27天前
已完结
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312
27天前
已完结
VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases
27天前
已完结
Targeting RET alterations in cancer: Recent progress and future directions
1个月前
已完结
Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies
1个月前
已完结
皖公网安备34019202002308
